Rockefeller Capital Management L.P. Buys 59,408 Shares of Cencora, Inc. $COR

Rockefeller Capital Management L.P. boosted its position in Cencora, Inc. (NYSE:COR) by 43.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 197,430 shares of the company’s stock after purchasing an additional 59,408 shares during the period. Rockefeller Capital Management L.P. owned about 0.10% of Cencora worth $66,682,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of COR. Kemnay Advisory Services Inc. purchased a new position in shares of Cencora during the 4th quarter valued at $25,000. Oakworth Capital Inc. purchased a new stake in Cencora in the 4th quarter worth about $26,000. Elyxium Wealth LLC bought a new stake in Cencora in the 4th quarter valued at about $27,000. Archer Investment Corp raised its stake in Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after acquiring an additional 47 shares during the period. Finally, Motiv8 Investments LLC purchased a new stake in Cencora during the fourth quarter valued at about $29,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

COR has been the subject of a number of research reports. Citigroup cut their target price on shares of Cencora from $405.00 to $355.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. UBS Group upped their price target on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Evercore set a $360.00 price objective on shares of Cencora in a report on Wednesday, April 8th. Morgan Stanley set a $342.00 price objective on shares of Cencora in a research note on Friday, May 8th. Finally, Robert W. Baird lowered their target price on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a report on Thursday, May 7th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $374.00.

Cencora Trading Up 0.1%

Shares of Cencora stock opened at $271.99 on Friday. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The company has a market cap of $52.92 billion, a price-to-earnings ratio of 20.86, a PEG ratio of 1.47 and a beta of 0.59. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The company’s 50-day moving average price is $284.59 and its 200-day moving average price is $324.35.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). The firm had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. Cencora’s revenue was up 3.9% on a year-over-year basis. During the same period in the prior year, the firm posted $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts expect that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a $0.60 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. Cencora’s dividend payout ratio is presently 18.40%.

Cencora announced that its Board of Directors has initiated a stock buyback program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board of directors believes its shares are undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.